6238-20-6

Basic information

• Product Name: 3-[(4-nitrobenzyl)oxy]-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one
• Synonyms: 3-(4-Nitro-benzyloxy)-7,8,9,10-tetrahydro-benzo[c]chromen-6-one; 3-[(4-Nitrobenzyl)oxy]-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one; 6H-Dibenzo[b,d]pyran-6-one, 7,8,9,10-tetrahydro-3-[(4-nitrophenyl)methoxy]-
• CAS NO: 6238-20-6
• Molecular Formula: C₁₃H₁₈N₂
• Molecular Weight: 351.3527
• Mol File: 6238-20-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 588.1°C at 760 mmHg
• Flash Point: 254.2°C
• Density: 1.37g/cm³
• Vapor Pressure: 8.2E-14mmHg at 25°C
• Refractive Index: 1.65
• CAS DataBase Reference: 3-[(4-nitrobenzyl)oxy]-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(4-nitrobenzyl)oxy]-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one(6238-20-6)
• EPA Substance Registry System: 3-[(4-nitrobenzyl)oxy]-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one(6238-20-6)

Safety Data

• Hazardous Substances Data: 6238-20-6(Hazardous Substances Data)

Upstream product

• 3731-38-2 3-Quinuclidinone 
• 62-53-3 aniline 
• 6530-15-0 N-(quinuclidin-3-ylidene)aniline 
• 1193-65-3 3-quinuclidinone hydrochloride 
• 6530-15-0 N-(1-aza-bicyclo[2.2.2]oct-3-ylidene)aniline 

Downstream Products

• 90094-20-5 3-aminoquinuclidine 

Relevant articles and documents

Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 – M5 muscarinic acetylcholine receptors

Novel quinuclidinyl N-phenylcarbamate analogs were synthesized, and binding affinities at M1-M5 muscarinic acetylcholine receptor (mAChR) subtypes were determined using Chinese hamster ovary (CHO) cell membranes stably expressing one

SUBSTITUTED AMINOQUINUCLIDINE COMPOUNDS

This invention is directed towards substituted aminoquinuclidine compounds useful as delta-opioid receptor modulators, delta-opioid receptor agonists useful as analgesics and delta-opioid receptor antagonists useful as immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.